New York, August 3 (FinanceEnquiry.com) – Analysts at Deutsche Bank Securities reiterate their BUY rating on the shares of Auxilium Pharmaceuticals Inc (NASDAQ: AUXL). The 12-month target price has been raised from $23 to $28.
In a research note published on August 1, the analysts mention that given higher revenues ie, +$6.1 million in tandem with lower than anticipated operating expenses ie, -$7.6 million, with EPS of $0.16 against estimate and the consensus of $0.05, first-ever profitable operating quarter has been reported by Auxilium Pharmaceuticals.
In addition to this, to reach $63 million, which is $8 million ahead of estimate, a very strong gain of 26 percent Y/Y has been reported by flagship TRT drug Testim, even though Xiaflex keeps on gaining traction slowly in contracture of Dupuytren.
Although, it is really difficult to view the launch of Dupuytren as anything but disappointing after 10 quarters on the market, still, driven by a number of indications with unmet need, Xiaflex is seen as one of the attractive long-lived assets with meaningful and considerable commercial potential, the analysts add further.
New York, June 19 (FinanceEnquiry.com) – Sony Xperia M is an upcoming sensation that is expected to enter mobile industry by the third quarter of this year. It has an optional dual SIM and has been...
Gold Plunges Since the Dollar Soars - June 18, 2013New York, June 18 (FinanceEnquiry.com) – Gold fell on the very first day of the week in view of the fact that the dollar soared, with investors keeping an enthusiastic watch on US Federal Reserve meeting of...
Investors Wait for Fed Meeting; Asian Stocks Improve - June 17, 2013New York, June 17 (FinanceEnquiry.com) – In view of the fact that investors wait for Federal Reserve meeting of this week, Asian stocks soared, with the regional benchmark index directed for its...
Retail Automobile Sales Soared in Houston Area in May - June 14, 2013New York, June 14 (FinanceEnquiry.com) – In the Houston area, retail sales of automobiles and trucks soared by nearly 5 percent in the previous month as compared with the similar time in 2012.
As...
HTC J: Giving Reasons to Fly with Joy - June 14, 2013New York, June 14 (FinanceEnquiry.com) – In August 2012, HTC J was launched with the motto to be at par with hopes of the users, waiting keenly to opt a phone that has been loaded with numerous top class features....
Jobless Applications Descend - June 13, 2013New York, June 13 (FinanceEnquiry.com) – Approaching bottommost stage in five years in an indication of flexibility for the US labor market, the number of Americans registering fresh applications for...
Pantech Vega R3 IM-A850L: Grand and Glamorous - June 13, 2013New York, June 13 (FinanceEnquiry.com) – A good battery backup is an essential property what everyone searches in latest mobile phones. Without desired performance of battery, it is really...
Deutsche Bank Securities Reiterates HOLD Rating on Texas Instruments (NASDAQ: TXN) - June 11, 2013New York, June 12 (FinanceEnquiry.com) – Analysts at Deutsche Bank Securities reiterate their HOLD rating on the shares of Texas Instruments Inc (NASDAQ: TXN). The 12-month target price is set to...
Deutsche Bank Securities Reiterates HOLD Rating on Masco Corporation (NYSE: MAS) - June 11, 2013New York, June 11 (FinanceEnquiry.com) – Analysts at Deutsche Bank Securities reiterate their HOLD rating on the shares of Masco Corporation (NYSE: MAS). The 12-month target price is set to...
Vertu Constellation Ayxta: Collection of Many Good Things - June 10, 2013New York, June 10 (FinanceEnquiry.com) – A few years back, Vertu Constellation Ayxta marked a noticeable entry and ruled on the hearts of buyers, who had always desired for having a class...